Domain Surgical, Inc.

Domain Surgical, Inc. announced today that its FMwand™ Ferromagnetic Surgical System has been selected as a finalist in the 2012 Medical Design Excellence Awards (MDEA) competition.

Domain Surgical, Inc., a medical device company developing advanced thermal surgical technology for soft tissue cutting and coagulation, today announced that it has released a new surgical resecting tool for its FMwand Ferromagnetic Surgical System.

Domain Surgical, Inc. announced today that Paul Hammond has been promoted to the position of Vice President of Operations.

Domain Surgical, Inc. announced today that Curtis Jensen has been promoted to the position of Vice President of Quality and Regulatory Affairs.

Domain Surgical, Inc. announced today that its FMwand Ferromagnetic Surgical System was successfully used for the first time in surgery on human patients.

Domain Surgical, Inc., announced today that it has raised $4.2 million in its Series B Preferred Stock financing from a combination of angel and venture capital investors.

Domain Surgical, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its FMwand(TM) Ferromagnetic Surgical System for soft tissue cutting and coagulation.

Domain Surgical, Inc. has received a Technology Commercialization and Innovation Program Grant award from Utah Science Technology Research initiative for research related to the validation of the company's technology for tissue sealing applications.